​What is Stiripentol?

Stipentol is an anti-epileptic drug that reduces seizures primarily by boosting the GABA system in the brain. By stabilizing the excitability of neurons, the frequency of seizures is reduced.

What is Stiripentol?

Stiripentol is an antiepileptic drug that is mainly used to treat seizures. It reduces the frequency of seizures by affecting nerve signals in the brain and can also be used in other neurological related treatments. Stiripentol is usually taken in tablet form, and the exact dosage depends on the patient's condition and the doctor's recommendation.

The mechanism of action of Stiripentol is mainly to exert antiepileptic effects by modulating the GABA (γ-aminobutyric acid) system in the brain. GABA is an inhibitory neurotransmitter that can reduce the excitability of neurons. Stipentol reduces the occurrence of seizures by enhancing the effects of GABA, increasing inhibitory signals in the brain, stabilizing overactive neurons. Special populations need to be extra careful when using medications.

Is stipentol used in special populations?

According to the drug instructions, special populations have the following precautions when using drugs:

1. Renal impairment

There are currently no formal pharmacokinetic and metabolic studies in patients with renal insufficiency. Stiripentol metabolites are excreted mainly through the kidneys and are not recommended for patients with moderate or severe renal impairment.

2. Liver damage

There are no formal studies on the pharmacokinetics of Stiripentol in patients with hepatic impairment. The drug is mainly metabolized by the liver and is not recommended for patients with moderate or severe hepatic impairment.

Special populations need to be cautious when using stitopentol. Next, pay attention to the following details and precautions related to medication.

What are the precautions for the use of Stiripentol?

When using Stiripentol, the following precautions must be taken into account.

1. Decreased appetite and weight loss

Stiripentol may cause decreased appetite and weight loss. In the study, the incidence of loss of appetite was 46%, and the incidence of weight loss was 27%. Growth in children should be monitored, and valproate dose adjusted if necessary.

2. Neutropenia and thrombocytopenia

Stiripentol may significantly lower platelet counts. Thirteen percent of patients in the study had platelet counts below 150,000/microliter. Blood tests are done before treatment and every 6 months thereafter.

Patients are advised to monitor relevant indicators regularly, adjust the treatment regimen according to the doctor's instructions, and deal with possible side effects and adverse reactions.

[Warm tips] Do not stop the drug or adjust the dosage without authorization. If you feel that the medication is not working well or that you experience side effects, contact your doctor immediately to adjust your treatment plan.